EP3455359
DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEINS USING GLUTAMINE SYNTHETASE INTRAGENIC COMPLEMENTATION VECTORS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.5.2017EP published:
9.3.2022EP application number:
17727027.9
EPO information:
European Patent Register
Max expiry date:
10.5.2037
Title in English:
DIRECT SELECTION OF CELLS EXPRESSING HIGH LEVELS OF HETEROMERIC PROTEINS USING GLUTAMINE SYNTHETASE INTRAGENIC COMPLEMENTATION VECTORSLanguage of the patent:
English
Timeline
Today
11.5.2017EP application
9.3.2022EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, Thousand Oaks, CA 91320, US
Inventor
Name:
KETCHEM, Randal R.Address:
Snohomish, Washington 98296, US
Name:
MCGREW, Jeffrey T.Address:
Woodinville, Washington 98072, US
Name:
FOMINA YADLIN, Dina A.Address:
Kirkland, Washington 98033, US
Name:
MUNRO, Trent P.Address:
Newbury Park, California 91320, US
Name:
AGRAWAL, Neeraj JagdishAddress:
Thousand Oaks, California 91320, US
Name:
DARIS, Kristine M.Address:
Newbury Park, California 91320, US
Priority
Number:
201662334966 PDate:
11.5.2016Country:
US
Classification
Categories:
C12N 15/10, C12N 15/65, C12N 15/67